US20250161447A1
University of Texas System
Aspects of the present disclosure describe dual chimeric antigen receptor (CAR) immune cells, as well as methods for making such cells and for use in treatment of cancer. Disclosed are immune cells comprising both anti-CD19 and anti-CD79b CARs and methods for use in treatment of B-cell …